Hayfin Supports Crown Lab GlaxoSmithKline Brands Acquisition

Hayfin Capital Management provided debt financing to support Crown Laboratories and Hildred Capital Partners’ acquisition of North American distribution rights of five OTC consumer brands from GlaxoSmithKline.